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1. Introduction
Among all surgery modalities known today, the heart surgery was one of the few that only in
the last century has become bravely discovered by surgeons, and the always gone toward safe
ways due to the tenacity and commitment of several scientists. The cardiopulmonary bypass
(CPB) was the responsible for the achievement of this status because due to this procedure,
the heart surgeries have become safer and some more complex defects could be approached.
This chapter aims to highlight some little discussed aspects of the CPB, taking into account
physiology and physiopathology aspects and some new perfusion technologies.
The first of these aspects concerns to the fact that the surgeons no longer worried about the
CPB, since the perfusionists began to make a quality support, besides the technical perform‐
ance of the procedure. Therefore, the surgeons must maintain and update their knowledge
about CPB due to the simple fact of maintaining its educational leadership over their team. On
the other hand, it seems that there is certain complacency in relation to the CPB since, in recent
times, the quality of the CPB apparatus ensures a strong safety for heart operations.
The second aspect concerns an intriguing detail. The CPB techniques are clearly distinct into
protocols for children and protocols for adults. Among adults would not be appealing the
preparation of protocols individually? For example, the elderly and diabetics, due to their
individual characteristics, would not deserve more appropriate protocols?
The third motivational aspect of this review may be the questioning of so harmful systemic
inflammatory reaction caused by exposure of blood to the non endothelized surface of the CPB
circuits. Due the fact that the inflammatory response is present in patients undergone off-pump
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surgery, the focus has changed to the concept that, more than the contact with the CPB circuit,
the contact of the blood with the operatory wound may be the most responsible by the
inflammation phenomenon in CPB. This even induced to the consideration of the contact of
the blood with serous membranes (pleura and pericardium), which have, as well known,
fibrinolytic activity as a cause of increased bleeding. Thus, the maintenance of the pleural
integrity in the dissection of the internal thoracic arteries has become an attractive detail of
surgical technique.
Finally, what is the motivation for the review title? Regarding the CPB in its current patterns,
would it be a consequence of empiricism or science? We are convinced that both empiricism
and science are extremely strong. Thus, the greatest motivation of this review was to provide
knowledge in order that the teams involved in cardiac surgeries may standardize their
knowledge about CPB and pursuit the enhancement of the scientific aspects that guide the
procedure.
2. Microcirculation
The cardiovascular system is a complex set of vessels, within which the blood circulates
through the body, pumped by the heart. In this way, the veins are responsible for the flow in
centripetal way, whereas the arteries are responsible for the flow in centrifugal way. Interposed
between the distal arterial and venous territories are the constituents of the microcirculation,
composed of arterioles, capillaries and venules. It deals with the exchanges between the blood
and tissues under the regulatory mechanisms of peripheral blood flow. The flow regulation
in the capillary bed occurs by means of the arteriovenous communications - which can deflect
the blood from the capillaries - and by means of the pre- and postcapillaries sphincters, which
actions control the blood volume and the pressure in the capillary bed. The flow control in the
microcirculation complies to metabolic changes as for both hormonal or neural stimuli [1]. We
can emphasize that, during the CPB, the circulation physiology is totally modified by the
introduction of a non pulsatile flow of the arterial side that differs from a high venous pressure
on the venous side of the circulation (Figure 1). This situation induces to adaptation mecha‐
nisms and those main are represented in Figure 2.
2.1. Adaptation mechanisms
Throughout all their extension, the components of the cardiovascular system are coated by
three basic tissue layers, suffering variations on the thickness in the different types of vessels
that constitute the system. These layers are: a) intimal layer, more internal, consisting of
endothelium, which the primary function is to avoid contact of blood with endothelial
thrombogenic substances b) thickness of the media layer, consisting (in more or less intensity)
of elastic and muscle tissue and; c) Adventitia or external layer, primarily composed of
conjunctive tissue [1.2].
In the pressure gradient found along the circulation, the pressure has a greater value in the
left ventricle reaching (during the systole), the mean value of 120 mmHg, decreasing then in
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the diastole and reaching around 0 mmHg. At the aortic root, the systolic pressure has the
same value found in the heart. However, the diastolic pressure decreases to around 80 mmHg.
It may be explained by the storage of energy imposed by the blood on the arterial wall during
Figure 1. Microcirculation in cardiopulmonary bypass (CPB)
Figure 2. Microcirculation in cardiopulmonary bypass (CPB)
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the systole and released during the diastole, ensuring the flow throughout all cardiac cycle. In
the distal arteries, both values of systolic or diastolic pressure decrease in relation to the origin
of the aorta, as well as the pressure and pulse (that is the difference between the systolic and
diastolic pressure).
The pulse pressure reaches zero value from the capillary territory, and the difference between
the pressure of the arteriolar extremity (about 40 mmHg) and the venous extremity (about 20
mmHg) creates a decreasing pressure gradient along the capillary. In the return to the heart
along the venous system, the blood pressure gradually decreases until reaching a value around
zero in the right atrium [2].
The microcirculation morphology is not uniform in all organs of the body, thus, in the central
nervous system, in the lungs, skin and the skeletal muscle the capillary endothelium is of
continuous type. The intestinal mucous, the exocrine glands, the renal glomerulus and the
choroid plexus are composed of fenestrated-type endothelium. Finally in the liver, spleen and
bone marrow, the endothelium is of discontinuous type [2]. The microcirculation flow is non
pulsatile as in the arteries, because the pulse pressure in the territory is null. Moreover, the
flow in capillaries is intermittent because the contraction in the pre-capillaries sphincters may
block the passage of blood during rest, allowing that the capillaries may oscillate opening and
closing.
The use of cardiopulmonary bypass (that in the majority of cases occurs with non pulsatile
flow) is considered harmful to the microcirculation, thus providing a "shunting" effect.
Moreover, the technique is responsible for other changes in circulation, such as a replacement
of reflex and chemoreceptors controls; increase of venous pressure; decreasing of colloid
osmotic pressure and manipulated temperature. The replacement of the physiological controls
induces the capillary flow not be intermittent and to be continuous instead, which increases
the pressure on the venous side forcing - in the microcirculation - the performance of com‐
pensation mechanisms for flow deviation. In the microcirculation, the continuous flow induces
to phenotypic cell adaptation that results in the development of systemic inflammatory
response syndrome (SIRS) [2]. Once initiated this response occurs activation of inflammatory
cells and triggering the coagulation cascade It also occurs the release of cell signaling protein,
generation of vasoactive and, cytotoxic substances associated to the production of a diversity
of microembolus.
Another way of microcirculation lesion related to the use of CPB is the formation of micro‐
bubbles that circulate in the blood flow and lodge in the capillaries causing obstruction,
promoting ischemia, inflammation, complement activation, platelet aggregation and forma‐
tion of blood clots [3].
In last decades, occurred considerable advances in CPB equipment in order to avoid the
development of SIRS. This achievement has had some success, but we cannot affirm the same
regarding to microcirculation lesion. The damage caused in the microcirculation can be
evidenced by the detection of products of several organs degradation that is, undoubtedly, an
important function to help the perfusionists to improve their techniques. One of the markers
that may meet this function may be the "mitogen-activated protein kinases" (MAPK) that have
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been involved in the vasomotor function since the microcirculation regulation includes the
miogenic tone [4].
3. CPB monitoring
Up to now, there is no method for monitoring of the regional perfusion during the CPB, which
leads to the question about which markers could be used to determine the adequacy of arterial
flow during the CPB. A discussion about possible parameters that may meet this purpose is
here presented as follows. This discussion was presented by one of the authors (PRBE), in 2007,
in the 34th Congress of the Brazilian Society of Cardiovascular Surgery [2].
3.1. Oxygen partial pressure of venous blood (PvO2) and venous saturation of venous blood
(SvO2)
The SvO2 presents some problems, among them, the fact that if the distant capillaries are not
equally perfused, tissues may not receive appropriate flows resulting in an increase of the
PVO2 or SVO2, mimicking a vascular shunt. Thus, the PVO2 or SVO2, despite the fact that
they are markers easy to be measured, they may not be related to the appropriate tissue
perfusion, not necessarily suggesting that the cell oxygenation is satisfactory [5].
3.2. Lactate
Among the problems presented by the lactate, we may mention that the release of this
substance in the blood demands blood flow; thus, high levels may be typically identified later
in the postoperative [5]. For the measurement of intraoperative lactate, the lactate/pyruvate
relationship may be a better method, but requires additional analytical instrumentation. The
systemic microvascular control may be disordered in the non pulsatile CPB. This disorder
causes "shunting" and increases lactate despite an apparent oxygen supply. Extreme hemodi‐
lution, hypothermia, low flow of CPB and excessive neuronal activation have been related to
lactic acidosis during CPB.
3.3. Partial pressure gradients of carbon dioxide between the venous and arterial blood
samples ("PCO2)
The PCO2 gradient between the arterial and venous blood samples (Ä PCO2) is a valuable
parameter for determining the adequacy of the CPB for a certain metabolic condition and may
help to detect alterations in oxygen demand (metabolic alterations that accompany the
temperature changes, CPB flows and drugs administration). Amongst the SvO2, which is
valuable patient's metabolic index during CPB, the Ä PCO2 can help to fulfill the role in the
adequacy of the tissue perfusion during surgery. This gradient, perhaps one of the best
parameters of tissue perfusion is rarely used by perfusionists perhaps due to its lack of
knowledge.
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3.4. Arterial pressure
An arterial pressure is extremely powerful in determining the adequacy of CPB. However, it
is difficult to establish what pressure level may indicate a best perfusion for each patient and
their physiopathological particularities.
4. Technologies
The introduction of CPB apparatus has solved obstacles that did not allow access to the inner
cavity of the heart; however, this fact revealed a myriad of complications from the response
of the organism to the aggressions imposed by the apparatus. Thus, throughout the years after
the introduction of the CPB, a paradoxical and new situation of a number of complications
related to the use of CPB were observed. Among these problems, the main are: a) the severe
inflammatory response that the patients develop when their blood are exposed to nonendo‐
thelial surface of the apparatus, b) the excessive hemodilution or the need of use of homologous
blood to fill the circuit, and c) the microcirculation lesion caused by the flow imposed by the
apparatus pumps.
Some technologies have been developed, modernly, aiming at the resolution of these problems.
Herein, we will approach some of these major advances.
4.1. Retrograde autologous priming
Since the creation of CPB, the cardiac surgeries present high risk for blood transfusion, due to
possible bleeding inherent to the surgery. The CPB circuit should be filled adding crystalloid
solutions to remove the air system resulting many times in severe hemodilution. Initially,
homologous blood was used for this purpose, but the risk of disease transmission and the lack
of donors contributed to search for alternative materials. The introduction of crystalloid
substances to fill the circuit (the called "pattern technique") solved that question, but the
frequent severe hemodilution induces to the need of new transfusions. Moreover, the hemo‐
dilution presents undesirable effects such as decreasing of the blood osmotic pressure and its
inability to carry oxygen causing acidosis, hypoxia, edema and clotting alterations [6]. Studies
evaluating the hemodilution effects showed an association with high rates of mortality and
other adverse conditions, which occur mostly when the hematocrit levels are lesser than 20%.
The low hematocrits during the CPB are associated to an increase of hospital mortality risks,
need of use of an intra-aortic balloon in per or postoperative and the need to return to the
perfusion after the end of CPB. In addition to these results, ethical and religious pressures
against blood transfusions, the scarcity of material and the risk of disease transmission, induce
to search alternatives to fill the system.
The resolution for these problems was attempted by the introduction of a new technique, the
Retrograde Autologous Priming (RAP), described initially by Panico and Neptune [7] in 1959,
and adapted later by several authors [5,8,9]. The basic idea consists of filling the CPB circuit
with the patient's own blood. To this end, the circuit is initially filled with crystalloid solution
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and then, allowing that the blood retrogradely flows from the aorta of the patient to the arterial
line, moving part of the acellular prime that was in the arterial line to the bag collector. After
that, the forceps of the venous line are opened allowing the venous blood drainage of the
patient. At the same time, the arterial pump is slowly moved in order to maintain a constant
liquid level in the venous reservoir. Then, the blood moves the remaining solution of the circuit
to the bag and the CPB may be initiated. If there is a need of liquid addition during the
perfusion, the prime stored in the collector bags can be introduced in the circuit by means of
the recirculation line. The technique of RAP has proved to be a safe, low cost and highly
effective in reducing the hemodilution associated to the heart surgery. This provides a blood
viscosity closer to the physiological blood, does not change the values of plasmatic proteins,
contributing to a better balance in osmotic pressure and reduction of edema. Moreover, the
technique does not compromise the function of the clotting factors and the vessel-regulator
hormones. As previously mentioned, the technique reduces the need of blood transfusions
and allows the control of the hematocrit to reach the intended levels by manipulating the
amount of crystalloid released by the backup bags.
The use of the technique allows less hemodynamic instability and rapid perfusion initiation.
The potential risks of the use of RAP technique are related to the reduction of hemodilution,
because the patients who are under hypothermia may present increase in the blood viscosity
about 10% to 30%. This can be solved by a moderate hemodilution during the procedure,
avoiding microcirculation impairment.
4.2. Pulsatile flow
The blood arterial flow in the organism is a pulsatile type, or that is, with changes in pressure
during systolic and diastolic phases; however, since its invention, the CPB determines a non
pulsatile flow, or that is, the pressure does not undergo significant variations over the
perfusion. This difference raised the suspicion that pulsatile blood flow may provide a most
appropriate and less harmful perfusion inducing a series of comparative studies between the
two systems. Promising results showing hemodynamic and metabolic improvement -com‐
pared to the conventional method - point to the pulsatile flow as an important tool to reduce
complications associated with the use of CPB [10-12].
It was suggested that the most benefic effect of the use of pulsatile flow may be in the territory
of the microcirculation, where the energy of the pulsatile flow eases the interstitial diffusion
by the oscillation of cell membranes and promotes the arterioles patency (which remain
collapsed during the non pulsatile flow). In addition to this is the fact that the continued
opening of arterioles reduces the stress produced by the decreased release of endothelial
vasodilators.
Although the literature presents conflicting data, many researchers have shown that the
pulsatile flow improves cerebral blood flow as well as avoiding the drop of renal function and
tubular changes found during the use of non pulsatile flow. Moreover, it was demonstrated
that the use of the technique increases the urine output and reduces proteinuria. It seems logical
that the pulsatile flow is beneficial or even needful to maintain the body's physiological state.
Therefore, in order to the extracorporeal support system may mimic the characteristics of
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pressure and flow as close as possible of the physiological characteristics, it need to seek the
exact wave type needed to reach a satisfactory pulsatile flow by the artificial pumps. This is a
controversial aspect, since there are defenders that only the presence of any pulse already
shows benefic effects.
4.3. Minicircuits
The severe inflammatory response associated with the materials used in CPB apparatus has
raised the idea that the reduction of the size of circuits may reduce the degree of this response
and minimize the harmful effects of the CPB; moreover, minor apparatus may reduce the prime
quantity needed and may minimize the hemodilution and the need for homologous transfu‐
sions.
The concept of mini-CPB combines the known clinical advantages of the impregnated circuits,
reduction of the prime volume and reuse of the aspirated blood from the surgical field. These
circuits are composed of a centrifugal pump, a membrane oxygenator, a heat exchanger, a "cell
saver" system for blood collection from the surgical field and an arterial filter, due to the higher
risk of air entering that these systems have [13].
Initially created to be used in CABG; throughout time and with increasing experience of the
teams, the mini-CPB has been showing increasingly useful, expanding the number of indica‐
tions for more complex procedures and replacing the conventional systems. A comparative
study between patients undergone conventional system and mini-CPB revealed some number
of microbubbles in the conventional system increasing the chances of these patients to develop
cognitive deficits [14]. Another study of the same nature revealed that the use of mini-CPB's
reduces hemodilution and thus the need for homologous transfusions associated to the
procedure. These observations in the study were associated with postoperative bleeding
reductions.
Despite the small number, the studies related to the new system have been showing superiority
in the benefits of minicircuits in relation to conventional systems up to now. Future studies
should be made to expand the indications on its use in a larger number of procedures.
4.4. Impregnated circuits
The interaction between the blood and nonendothelial surfaces of the CPB circuit is responsible
for the development of severe inflammatory response based on the activation of complement
and the kallikrein system. In addition to that, the release of cytokines contributes to severe
complications in the peri and postoperative and increases the surgical morbidity and mortality.
These problems can be solved by means of materials that allow the biocompatibility to the
system, or that is, materials that avoid the deleterious effects of nonendothelial materials of
the apparatus in contact with the patient's blood. It was proven that the heparin, commonly
used due to its antithrombotic properties, is capable of providing properties of biocompati‐
bility, inhibiting by the contact the activation of complement and adsorbing lipoproteins to
create a surface that mimics the cell membranes.
Cardiac Surgery - A Commitment to Science, Technology and Creativity18
The use of heparin in the coating of the CPB apparatus has proved to be capable to reduce
blood loss, as well as the need for blood transfusions or derivatives. Moreover, the achieved
reduction of inflammatory response has benefic effects on the patient's clinical evolution.
Mangoush et al. [15] also showed that the substance reduced the ventilation time in 78 minutes,
as well as the hospitalization time in 0.5 days. Because of these reductions, the use of the
mentioned substance also allows overriding economy in terms of financial costs.
Phosphorylcholine is a coating that allows system biocompatibility. This phospholipid is
frequently associated to a copolymer (methacryloyl- phosphorylcholine/lauryl-methacrylate
(MPC:LM). Its characteristics allow coating of other polymers, showing stability and little
waste by leaching. It has proved that the coating resists to the fibrinogen adsorption, connec‐
tion and activation of platelets [16, 17]. The effects on the clinical status of the patient still need
further studies, but in the few performed studies were found the reduction of immediate
postoperative bleeding, preservation of platelets and a positive effect on the generation of
complement.
A third group of products is also commercially available and involves the concept of "micro‐
domains" to minimize the interactions between the surface, the cells and the proteins. The new
technology uses copolymers, from which hydrophobic and hydrophilic "microdomains" are
interchanged on the surface of contact with blood. The control of the distances among these
"microdomains" allows them to compete among themselves ("microdomain" inhibiting effect
of another), which limits the adsorption of protein [18].
The cell membranes of circulating leukocytes and platelets is also under the same competitive
interaction between the surface and the membrane constituents minimizing the cellular
connection. A few clinical studies have shown inhibition of the generation of thrombin and
fibrinolysis during the use of these coatings. Moreover, there is protection of platelets with
reduction of their activation.
Some other materials are commercially available, but almost all of them still requiring more
studies to confirm their benefits. Future advances in materials engineering focusing the search
of products with high biocompatibility will allow better results in reducing complications by
the use of CPB.
5. Cardiopulmonary bypass in elderly
In recent years, world population is going through an "aging process". This increase of the
elderly population additionally brings increase of the prevalence of diseases inherent to this
age-group, among them the cardiovascular diseases. As a result, the heart surgery in elderly
is increasing, and some procedures, such as CABG, correction of valve lesions (specially the
aortic valve), and repair of aneurysms and dissections of the aorta are becoming common.
The peculiarities of this population bring as a challenge to patients selection the adoption of
peri- and postoperative cares, and the choice of surgical techniques that reduce the morbidity
and mortality in those patients. As elderly patients may undergone to high-risk surgical
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procedures it is necessary to understand the physiological alterations, in order to prevent no
complications as early as possible. In addition, it is crucial to consider the expectation and
quality of life that intervention will bring to the patient [18, 19].
Some physiological aspects of aging involve in well known particularities such as cardiovas‐
cular, lung and kidney physiologies, which are extremely valuable for the CPB planning. These
particularities of the elderly physiology justify one of the initial propositions of this study
(special protocols for elderly), motivating also the pursuit for excellence in pre- and perioper‐
ative care of these patients. Preexisting diseases have a greater impact on morbidity and
mortality than this age for itself. Meanwhile, although the age alone does not constitute a risk
factor for heart surgery, it may not be an extreme the individualization of CPB protocols for
elderly [18, 19].
The preparation of the CPB does not differ significantly from the perfusion for adults in
general, however, taking into account that the elderly is characterized by reduced organic
reserves, it needs higher stability during perfusion. The peculiarities of the elderly include
higher systolic pressure due to greater rigidity of the arteries, reduction of the blood flow brain
and lower oxygen consumption by the tissues. Also, due to higher incidence of neurological
complications by microembolia, it is recommended the use of the filter in the arterial line. Other
recommendations include maintaining blood pressure at higher levels than the average 70-80
mmHg at all stages of the infusion; the hematocrit between 25 and 30% and an oncotic normal
pressure, which is obtained by adding synthetic colloids, plasma or albumin, avoiding cerebral
and pulmonary edema. Concerning to the temperature, is preferable the normothermia or
rapid hypothermia [20].
6. Cardiopulmonary bypass in the diabetic patient
Diabetic patients undergoing on-pump heart surgery present increased rate of severe compli‐
cations. The oxidative stress is about two times high in diabetics. Furthermore, some studies
have reported that the inflammatory response is different when the two groups are compared.
Despite not yet entirely known, the metabolism of nitric oxide (NO) was involved as partici‐
pating of these alterations. The different possible mechanisms already outline therapeutic
possibilities to reduce the deleterious effects of the CPB in these patients.
The suspicion that the NO may be involved in the physiopathology related to the use of
CPB  motivated  many  studies,  many  of  them  comparing  different  parameters  between
diabetics and nondiabetic patients. Matata and Galiñanes performed a study in which they
measured the stable metabolites levels of  NO (NOx) in urine and blood. These metabo‐
lites are the main way of NO degradation and due the fact that they do not suffer immediate
degradation, their measurement is a reliable indication of the production of NO. The results
showed  that  NOx  levels  are  already  high  in  basal  conditions,  in  the  diabetic  group,
explaining  the  greater  susceptibility  to  oxidative  stress.  Moreover,  the  levels  of  these
metabolites suffer significant additional increase during heart surgery that was not observed
in the nondiabetic group [21, 22].
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It is known that the reaction between NO and the superoxide anions induces to the formation
of powerful oxidizing peroxynitrite (ONOO-), which can exacerbate the oxidative stress in
diabetics. Those peroxynitrites are the main generators of hydroxyl radicals that can cause
serious lesions and cell death. Moreover, the free radicals generated during the CPB induce to
peroxidation of lipids and proteins that change the enzyme activity. Based on the fact that the
pretreatment with antioxidants before the CPB reduces oxidative attack, interventions with
antioxidants may represent possible therapeutic aim.
It is suspected that the cause of increase of NO is the increased expression of inducible NO
synthase (iNOS) in these patients [21]. The suspicions of implication of the NO in the physio‐
pathology of the adverse events observed after CPB has induced studies about NO donors.
Moreover, these substances are usually used to hemodynamic control during and after CPB,
and the effects of exogenous NO on oxidation and inflammatory response concerning the
clinical status of patients were unknown.
These studies showed that exogenous NO significantly reduced the oxidative stress in diabetic
patients and differently affected inflammatory response [22]. In these two groups of patients,
the use of NO donors decreased the formation of nitrotyrosine protein, but only in diabetics
there was a significant reduction in formation of lipid hydroperoxides and protein carbony‐
lation. These observations may be explained by the reduction of formation of endogenous NO
by means of exogenous NO. Thus, the results showed that exogenous NO seems to present a
powerful antioxidant activity in humans, which may allow the extension of its use to the usual
hemodynamic control.
Alteration in NOx levels also were compared in response to the administration of nitroglycerin
(TNG), revealing that this substance, in accordance with the findings described above, is also
able to reduce significantly urinary and plasmatic levels of NOx in diabetics. One hypothesis
about the way the TNG exerts this effect on NO metabolism may be by the negative regulation
on the activity of constitutive NOS. Another possibility may be that the TNG reduces the
capture of L-arginine (precursor of NO) by cells, emphasizing that the two mechanisms are
not mutually exclusive and may occur together, inducing the reduction of the NOx levels in
diabetics [22].
Study about the use of TNG on the inflammatory response [21] showed that this drug increased
the IL-8 levels, and plasma elastase in diabetics, whilst in nondiabetic group there increased
complements activation. These findings show that the inflammatory response in diabetic
patients is different from the response in nondiabetics and, moreover, the answer to the TNG
is also different between the two groups.
There are also reports of minor hospital stay (marginally not significant) in diabetic patients
who received TNG, although it increases the release of some components of the inflammatory
response of CPB in both groups of patients. Thus, despite the benefits, the increase of the
inflammatory response observed by NO donor drugs regarding to their use - requires care,
especially in patients under proinflammatory conditions.
Other studies have shown a reduction in the complement activation to the use of another NO
donor (sodium nitroprusside) [23]. This may indicate that the donor type and the time of use,
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as well as, the dose of administration may be beneficial in determining the effect of these agents
in the inflammatory cascade. Thus, as the oxidative stress is increased in diabetic patients, its
reduction, by NO donors, may be a possible therapy.
6.1. Vasoplegia in diabetics
Another adverse effect of the use of CPB is the vasoplegic syndrome, which is characterized
by the appearance of severe hypotension, reduction in systemic vascular resistance and
arteriolar reactivity, increase of need for volume replacement and vasopressor therapy, and
appropriate or high cardiac output. Nitric oxide mediators were discovered as participants of
this syndrome, allowing also some therapies. Few studies characterize this syndrome in
diabetics and, as previously discussed, diabetics present an altered NO metabolism; moreover,
some differences in control of perfusion regulation between the two groups of patients are
known [24].
The alterations presented in healthy patients along surgery induced to an increase in the pCO2
concentrations, acetylcholine, ADP, that with hypoxia stimulate the NOS to produce NO,
which function is to regulate the flow by means of vasodilation. In diabetics, the changes that
occur in this flow regulation mechanism are characterized by insufficient production of NO,
despite the presence of appropriate stimuli on the NOS. This effect sums to the thickening of
the basal membrane and may block the passage of the little remainder NO that was produced,
avoiding that it may reach the vascular smooth muscle and exerts its vasodilator effect [25].
7. Inflammatory reaction and vasoplegic syndrome associated to
cardiopulmonary bypass
The physiopathology of post-CPB vasoplegia is multifactorial, with no final consensus on its
real mechanism. The emphasis will be on systemic inflammatory reaction with possible
"trigger" from the contact of blood with nonendothelial surfaces of CPB and the possible
mechanism related to the vasopressin deficiency.
7.1. Systemic inflammatory reaction
The modern era of heart surgery had its beginning when the CPB technique was introduced
in the beginnings of 50' decade. The CPB is essential for the majority of cardiac surgeries, but
an undesirable inflammatory reaction occurs as a result of its use. To understand the vasoplegic
syndrome physiopathology there are many hypotheses including a) viral and bacterial
infections b) immunological reactions related to anti myocardial antibodies c) anaphylactoid
reactions associated to anesthetics, protamine, heparin and the CPB circuit itself [26].
Many factors during the CPB, dependent (exposure of blood to surfaces and not physiological
conditions) or independent of the CPB material (surgical trauma, ischemia-reperfusion of the
organs, changes in body temperature and release of endotoxins), have been reported as
inducers of a complex inflammatory response. These factors include the activation of the
Cardiac Surgery - A Commitment to Science, Technology and Creativity22
complement system, release of cytokines, leukocyte activation and the expression of adhesion
molecules, in addition to the production of various substances, such as oxygen free radicals,
arachidonic acid metabolites, platelet-activating factor (PAF), NO and endothelins. Such
inflammatory cascade may contribute to the development of postoperative complications,
including respiratory failure, renal dysfunction, hemorrhagic disorders, neurological dys‐
function, changes in liver function, and finally failure of multiple organs. More recently, it was
observed that this antiinflammatory response may initiate during and after CPB. This complex
chain of events has strong similarities with sepsis.
For the CPB circuit, it can be emphasized that its incidence is higher with the use of bubble
oxygenators in relation to the membrane oxygenators. Its real physiopathology remains unclear
and may be described a logical sequence of events: proinflammatory and/or inflammatory
stimuli with activation of the complement system; release of various cytokines (interleukins,
tumor necrosis factor, platelet activating factor, etc.); activation of the inducible nitric oxide
synthase (iNOS); production of NO; activation of guanylate cyclase with an increase of cyclic
GMP which leads to the refractory vasoplegia even to the use of high doses of adrenergic amines.
There is also a tendency for diffuse bleeding by the NO antiplatelet activities of NO [26]. The
schematic representation of this inflammatory response can be observed in Figure 3. Regard‐
ing the NO participation, it is curious to observe that a clinical study measuring nitrates in urine
and blood of patients undergone on-pump heart surgery, has not shown a correlation be‐
tween endogenous NO and low systemic vascular resistance [27].
In relation to the individually involved mechanisms, some data worth highlighting:
1. The clinical relevance of the complement activation itself is still uncertain. Several studies
have linked the postoperative morbidity to the complement activation;
2. The prevention of neutrophils adhesion may bring practical benefits, but these benefits
may be associated to a greater risk of infection;
3. The leukocytes activation may release large amounts of oxygen free radicals, including
the superoxide anion, hydrogen peroxide, hydroxyl radical and the oxygen itself. These
radicals act on lipidic membranes by increasing the permeability which can involve the
cardiac and pulmonary functions;
4. The metabolism products of arachidonic acid (prostaglandins, leukotrienes and throm‐
boxane A2) may be counterbalanced by the concomitant production of vasodilators
prostaglandins such as the prostacyclin (PGI2). The leukotrienes may be responsible for
the increase of capillary permeability;
5. Endotoxin levels may increase during and after CPB. The sources of endotoxins are highly
diverse. However, the most significant source is related to the intestines. The splanchnic
vasoconstriction during the CPB may induce to ischemia and increase of the permeability
of intestinal loops with the release of endotoxins into the blood flow. The endotoxins levels
are related to the initial vasoconstriction, time of aortic clamping and hypo-oncotic state
during the CPB;
Adult Cardiopulmonary Bypass in the Twenty-First Century — Science, Art or Empiricism?
http://dx.doi.org/10.5772/57108
23
6. The release of cytokines may be stimulated by a number of factors, including ischemia-
reperfusion, the complement activation, the release of endotoxins and the effect of other
cytokines;
7. The platelet-activating factor (PAF) has a crucial role in the lesion of myocardial ischemia-
reperfusion and may also have hemodynamic deleterious effects during the CPB;
8. The excessive production of NO, by the expression of iNOS, may be the result of these
multiple mechanisms, being the biggest cause of the vasoplegic syndrome;
9. There may be an increase of endothelin levels during the CPB, surgical treatment of
congenital cardiopathy, valve disease and CABG. Its role is not clear in the physiopathol‐
ogy of the post-CPB vasoplegia. Otherwise, if the vasoplegia is a consequence of a large
release of NO, its opponent vasoconstrictor effect does not manifest.
Figure 3. Outline of the inflammatory response generated by cardiopulmonary bypass (Adapted from Wan et al.
1997)1
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7.2. Vasopressin-dependent mechanisms
Landry et al. [28] showed that the levels of vasopressin in septic shock are abnormally low.
This fact supports the hypothesis that, in sepsis, there may be a decrease in vasopressin stocks
and/or a baroreflex dysfunction, causing an insufficient secretion of vasopressin. These authors
reported also situations of sepsis with refractory hypotension, which was recovered by the
injection of vasopressin that led to a reduction of the needs of catecholamines.
Considering the similarities of the inflammatory response in sepsis and post-CPB vasoplegia,
Argenziano et al [29] published a retrospective analysis of 40 cases of distributive shock after
heart surgery treated with vasopressin. These same authors included in their experience with
this drug the heart transplant and patients who underwent mechanical circulatory assistance.
In these patients, there was no hypertensive rebound, peripheral or mesenteric ischemia,
closed to an improvement in blood pressure levels and decrease of the needs of catecholamines.
Based on this experience Talbot et al. [30] published the case of a patient who had refractory
hypotension at the beginning of the CPB, possibly associated with high levels of potassium
cardioplegia and the prolonged use of diuretics and ramiprilat. It was used a unit of vaso‐
pressin bolus with immediate pressure response, suspension of catecholamines, and without
any observable collateral effect. The efficiency and safety of this new and promising agent
pressure needs further observation.
7.2.1. Possible therapeutic strategies
The corticosteroids have been used in heart surgery for more than 30 years attributed to a
number of effects: 1) improvement on hemodynamic conditions, 2) lower vasoconstriction
with improved tissue perfusion, 3) cellular effects such as stabilization of the lysosome
membrane, 4) inhibition of phospholipase A2 activation with stabilization of lipid cell
membranes, 5) antiinflammatory activity with lower release of cytokines and inhibition of
complement activation and, 6) Selective inhibition of iNOS demonstrated experimentally by
the action of dexamethasone.
Although it is use has an experimental and logical basis, many studies failed to demonstrate
it is real effectiveness. Some studies try to attribute an anti-inflammatory activity to the
aprotinin in situations of ischemia-reperfusion and association with the use of oxygenators
with heparinized surface, but the controversial aspects about their concrete effectiveness do
not justify its routine use.
Similarly, the use of antioxidants in the preoperative, the use of surface oxygenators with
heparinized surface and depletion of leukocytes are also speculative subjects. However, the
use of techniques of ultrafiltration and "cell savers" may be considered beneficial because these
techniques are employed almost as a routine in American services, where there is the impres‐
sion that the vasoplegic shock is not considered a serious problem. The removal of proinflam‐
matory substances and the decrease of the contact of white blood cells with the CPB circuit
certainly are useful functions of these two techniques [26]. These strategies are represented in
Figure 4.
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7.3. The inhibition of guanylate cyclase by methylene blue as therapeutic propose for
vasoplegia associated to cardiopulmonary bypass
The vasoplegic syndrome associated with the CPB was described by Gomes et al. [31] in 1994
and Evora et al proposed that the vasoplegia was dependent on the cyclic GMP system [32,
33]. In clinical impossibility of NO production from the L-arginine, it was proposed the
inhibition of guanylate cyclase by the use of methylene blue. Nowadays, this approach seems
to be the most reasonable proposal therapy since it does not interfere with the Nitric Oxide
synthesis, and as a medication widely used in other clinical conditions. The action of methylene
blue involves at inhibition of the guanylate cyclase avoiding the increase of cyclic GMP and
thus avoiding the endothelium-dependent relaxation mediated by NO [34, 35].
Although methylene blue has been used to treat vasoplegic syndrome, over 15 years, there are
few human studies to adopt a treatment protocol. Only three studies involving a larger number
of patients deserves, due to their importance, the inclusion in this review about CPB [36]. In
Figure 4. Possible therapeutic strategies to reduce the inflammatory response during cardiopulmonary bypass
(Adapted from Wan et al. 1997)
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2003, Leyh et al. [37] reported 54 cases of cardiac surgical patients with no bacterial endocarditis
who were treated with methylene blue with response to the treatment of over 90% of patients.
Levin et al. [38] reported incidence of 8.8% of vasoplegic syndrome in 638 patients, with 56
patients randomized to receive vasoplegic methylene blue or placebo.
There were no deaths in the group that used methylene blue and the vasoconstrictor amines
could be discontinued in a short time, with consequent lower morbidity and mortality. In the
placebo group occurred two deaths, the use of amines lasted around 48 hours with the highest
incidence of respiratory and kidney problems. This study supported the idea of methylene
blue as efficient treatment of the vasoplegic syndrome.
Regarding  to  prevention  of  the  vasoplegic  syndrome,  Ozal  et  al.  [39],  in  a  prospective
randomized study showed that methylene blue was associated with a lower incidence of
vasoplegia and less use of sympathetic amines. The criterion for inclusion of more patients
in the study protocol was (in addition to the use of heparin) the use of ACE inhibitors.
These two drugs are, up to now, the only ones considered as a risk factor for vasoplegic
syndrome.
Finally, this study may not let to make considerations about the "unanswered question" about
the use of methylene blue: Why does the vasoplegic presentation reverse itself promptly
sometimes, and occasionally seem not effective? Recently, a brilliant doctoral thesis was
defended at the Federal University of Florianopolis (which has already been published by
Fernandes et al. [40]) and brings some extraordinarily powerful data to attempt to answer that
question. Based on a mice sepsis model, the authors demonstrated that the guanylate cyclase
enzyme dynamics allows a "window of opportunity" for the efficiency of methylene blue. In
the first eight hours, no longer occurs vasoreactivity not only by the action of amines, but also
by the action of nitric oxide donor drugs.
This phase coincides with increased expression of iNOS. Between eight and sixteen hours, the
expression of guanylate cyclase gradually cancels itself, probably by excessive production of
nitric oxide, and thus in this stage the methylene blue may not act. Later, between sixteen and
twenty-four hours, there would be a "de novo" synthesis of guanylate cyclase and the meth‐
ylene blue may be effective again.
Considering these findings, we start to use the infusion of methylene blue even without
an apparent effectiveness, waiting for the "window of opportunity", or that is, for the "de
novo"  synthesis  of  guanylate  cyclase.  One  of  our  diabetic  patients,  who  developed
vasoplegic syndrome during the CPB, presented an excellent response to methylene blue
but repeated serious vasoplegia in the surgical ICU without response to methylene blue.
We  maintained  infusion  of  methylene  blue  associated  to  high  doses  of  adrenaline  and
noradrenaline.  At  the  fourth  postoperative  day,  we  repeated  new endovenous  bolus  of
methylene blue and the response was terrific and on the fifth day no longer was needed
for infusion of amines to maintain arterial pressure and the stability of systemic vascular
resistance in normal values.
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8. Lung and brain perfusion in cardiopulmonary bypass
The pulmonary infusion is temporarily interrupted during the CPB causing ischemia followed
by reperfusion lesion. It is known that the blood supply of the lungs performs by means of two
different systems: the pulmonary and bronchial circulation. The bronchial circulation irrigates
the supported tissue of the lungs with conjunctive tissue, septum and small bronchioles, while
the pulmonary capillary circulation is made by the pulmonary artery branches. Connections
between the pulmonary and bronchial circulations are particularly valuable in the absence of
pulmonary circulation. In long-term, the bronchial circulation may extend and ensure the
functions of affected areas [41].
Changes in pulmonary function after CPB is still extremely significant because they are
associated with increased morbidity and mortality. Two main mechanisms, the systemic
inflammatory response and normothermic ischemic lesion have been implicated by these
alterations. To avoid or prevent these alterations, the perfusion of pulmonary artery during
the CPB with aortic clamping has been professed [42]. However, the perfusion of the pulmo‐
nary arteries during heart surgery with the use of CPB is not an usual and routine practice,
even though the concept of ischemia lesion and pulmonary reperfusion is being showed
(clinically and experimentally) as responsible for the deleterious effects in the postoperative
period.
Some experimental studies have demonstrated that the perfusion maintenance of the pulmo‐
nary artery, with or without drugs, has the advantage of improving pulmonary function after
CPB [42, 43]. The advantages of the perfusion of the pulmonary trunk were recently demon‐
strated in a postdoctoral work developed in the Escola Paulista de Medicina - UNIFESP [44].
The possibility of maintenance of ventilation during the CPB improves the respiratory function
of patients undergone heart surgery with CPB is controversial. Meanwhile, metanalysis
performed with a strategy based on evidence identified nine studies among 187, which when
carefully examined showed no evidence favorable to the maintenance of ventilation during
the CPB.
That study showed a variety of strategies including ventilation: a) CPAP with positive
pressure, 5-15 cmH2O, b) high-frequency ventilation (with 100 resp/min), c) inspired fractions
of oxygen from 21 to 100% and, d) bilateral CPB using the lungs to oxygenate the blood during
the CPB. Although some small and transitional benefits have been observed with CPAP of
10cmH2O, no clinical benefit for any of ventilatory strategies during the CPB was established.
Therefore, ventilation during the CPB may not be considered to improve the respiratory
function of postoperative patients undergone heart surgery with CPB [45].
Unlike the pulmonary perfusion during the CPB, the selective brain perfusion has become
consensus and may bring additional benefits to hypothermia during aortic surgery. In general,
if it is accepted that the continuous perfusion brain promotes better protection brain, its
association with hypothermia is still subject of controversy. One of them concerns the initial
period of hypothermic cardiac arrest that may negatively affect the late evolution of surgical
patients. Experimental evidence seem to demonstrate that the hypothermia does not involve
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these developments, perhaps by mechanisms of self-regulation of cerebral blood flow which
rises along with their adaptation to the metabolic oxygenation [46].
Finally, it would be unfair if we not mention that the content of a class, showed on the Internet
provided by Larson, was one of the motivating factors of this review [47].
9. Essential informations
In the conclusion of this critical review, follows some information that we consider essential
throughout the text.
• Surgeons must maintain and improve their knowledge about CPB based on the basic fact
of maintaining its educational leadership over their team. On the other hand, there is certain
tolerance to the CPB apparatus, because the quality of the material ensures large margin of
safety for heart operations.
• During CPB, the circulation physiology is fully modified by the introduction of a non
pulsatile flow of arterial side opposed to high venous pressure on the venous side of the
circulation.
• Together with the SvO2, which is useful patient's metabolic rate during the CPB, the ÄPCO2
can help to fulfill the role in the adequacy of tissue perfusion during surgery. That gradient,
perhaps one of the best parameters of tissue perfusion, maybe for lack of knowledge, is
rarely used by perfusionists.
• The CPB techniques are clearly divided into protocols for children and protocols for adults.
Therefore, among adults, would not be interesting the elaboration of protocols individually?
For example, the elderly and diabetics, due to their individual characteristics. Do they not
deserve more appropriate protocols?
• What about the systemic inflammatory response, caused by blood exposure to the nonen‐
dothelial surface of CPB circuit?. From verification that the inflammatory response is present
in patients operated off-pump, the focus changed to the concept that, rather than contact
with the CPB circuit, the contact of blood with the operatory wound may be more respon‐
sible for the phenomenon of inflammation in CPB.
• Why does the vasoplegic syndrome sometimes reverse itself promptly, and sometimes seem
not be effective? Model of sepsis in mice revealed a "window of opportunity" for the
efficiency of methylene blue in helping to restore the systemic vascular resistance. This
window of opportunity depends on the dynamics of action of guanylate cyclase that by the
intense release of NO by action of iNOS "saturates" itself, losing its activity for a few hours
when their “de novo” synthesis occur "again"; when the methylene blue becomes effective
again. Therefore, perhaps should be a good idea to maintain the infusion of methylene blue,
since the “de novo” synthesis of the enzyme occurs between 18 and 24 hours.
• New technologies (impregnated circuits, "retrograde prime, minicircuits of CPB, techniques
to minimize the inflammatory reaction") have been "beneficial", "promising", without
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becoming unanimity in the face of routine and conventional techniques of CPB. Thus, as
already mentioned, we must "persist in our daily faith that the body is incredibly able to
resist and mostly often fixes this physiological chaos."
• Alterations in pulmonary function after CPB is a particularly pertinent question because
they are associated with increased morbidity and mortality. Two main mechanisms, the
systemic inflammatory response and normothermic ischemic injury have been implicated
by these alterations. In order to avoid or prevent these alterations, the pulmonary artery
perfusion during the CPB with aortic clamping - although not consensual - has been
recommended.
• Although some minor and temporary benefits have been observed with CPAP of 10 cmH2O,
no clinical benefit for any of ventilatory strategies during the CPB was established. Thus,
pulmonary ventilation during the CPB may not be considered improve the postoperative
respiratory function of patients undergone on-pump heart surgery.
• Unlike the pulmonary perfusion during the CPB, the selective perfusion brain has become
a consensus and may introduce additional benefits to hypothermia during aortic surgery,
but its association with hypothermia is still controversial. Experimental evidences seem to
show that the initial hypothermia does not compromise this evolution, perhaps by mecha‐
nisms of self-regulation of cerebral blood flow which rise along with their metabolic
adaptation to the oxygenation. Experimental evidences seem to show that the initial
hypothermia does not impair these developments, perhaps by mechanisms of self-regula‐
tion of cerebral blood flow, which rise along with its metabolic adaptation to oxygenation.
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